• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT AFP; ALPHA-FETOPROTEIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND DIAGNOSTICS DIVISION ARCHITECT AFP; ALPHA-FETOPROTEIN Back to Search Results
Catalog Number 03P36-30
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/25/2020
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.All available patient information was included.Additional patient details are not available.
 
Event Description
The customer observed a falsely elevated architect afp result on a (b)(6) year-old female patient.The following data was provided: initial result, on (b)(6) 2020, was 11 ng/ml, a few days later, it was repeated at another hospital with a result of about 4 (unknown unit of measure).It is unknown on what platform the repeat result was generated.It is unknown if the patient is pregnant.There was no impact to patient management.
 
Manufacturer Narrative
The complaint investigation for falsely elevated architect afp results included a search for similar complaints, review of complaint text, trending data, labeling, and device history records.Return testing was not completed as returns were not available.Using worldwide field data, the performance of reagent lot 08069fn00 and associated sublots manufactured with the same material were evaluated and are performing similar to other reagent lots in the field confirming there was no systemic issue.Trending review determined no adverse trend for the issue for the product.Device history record review on lot 08069fn00 did not show any potential non-conformances or deviations.Labeling was reviewed and found to adequately address the issue under review.All specifications were met indicating that the lot is performing acceptably.Based on the information provided and abbott diagnostics' complaint investigation, no systemic issue or deficiency of the architect afp assay, lot number 08069fn00, was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT AFP
Type of Device
ALPHA-FETOPROTEIN
Manufacturer (Section D)
ABBOTT IRELAND DIAGNOSTICS DIVISION
finisklin business park
diagnostics division
sligo NA
EI  NA
MDR Report Key10181729
MDR Text Key225941545
Report Number3008344661-2020-00051
Device Sequence Number1
Product Code LOK
Combination Product (y/n)N
PMA/PMN Number
P120008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 07/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/21/2020
Device Catalogue Number03P36-30
Device Lot Number08069FN00
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/01/2020
Initial Date FDA Received06/22/2020
Supplement Dates Manufacturer Received07/14/2020
Supplement Dates FDA Received07/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000 PROCESSING MODULE,; ARCHITECT I2000 PROCESSING MODULE,; LIST# 03M74-01, SERIAL# (B)(6) ; LIST# 03M74-01, SERIAL# (B)(6)
Patient Age53 YR
-
-